Design of highly potent HIV fusion inhibitors based on artificial peptide sequences

Weiguo Shi; Lifeng Cai; Lu Lu; Chao Wang; Kun Wang; Liang Xu; Sha Zhang; Han Han; Xifeng Jiang; Baohua Zheng; Shibo Jiang; Keliang Liu

doi:10.1039/C2CC35973A

Design of highly potent HIV fusion inhibitors based on artificial peptide sequences†

Weiguo Shi,‡^a Lifeng Cai,‡^a Lu Lu,^b Chao Wang,^a Kun Wang,^a Liang Xu,^a Sha Zhang,^a Han Han,^a Xifeng Jiang,^a Baohua Zheng,^a Shibo Jiang*^b and Keliang Liu*^a

Author affiliations

* Corresponding authors

^a Department of Medicinal Chemistry, Beijing Institute of Pharmacology & Toxicology, 27 Taiping Rd, Haidian District, Beijing 100850, China
E-mail: keliangliu55@126.com
Fax: +86-10-68211656

^b Key Lab of Medical Molecular Virology (Ministries of Education and Health), Shanghai Medical College and Institute of Medical Microbiology, Fudan University 130 Dong An Road, Xuhui District, Shanghai 200032, China
E-mail: shibojiang@fudan.edu.cn
Fax: +86-21-54237465

Abstract

Specific interactions were introduced between an artificial heptad repeat peptide template and HIV-1 gp41 for fusion inhibitor design, using a structure based rational design strategy. The designed peptides are nonhomologous with naturally occurring peptide and protein sequences, specifically interact with HIV-1 gp41, and show strong anti-HIV activity.

Chemical Communications

Design of highly potent HIV fusion inhibitors based on artificial peptide sequences†

Abstract

Supplementary files

Article information

Download Citation

Permissions

Design of highly potent HIV fusion inhibitors based on artificial peptide sequences

Social activity

Search articles by author

Spotlight

Advertisements